Breaking Class Action News & Legal Updates

The bellwether trial of the class action alleging Johnson and Johnson's DePuy ASR hip implant caused patients serious injuries will begin later this year.

According to the Sun-Sentinel, Florida was the source of 35% of the country's force-placed insurance in 2011, totaling $1.2 billion from policyholders.

A new lawsuit alleges drug manufacturer Pfizer marketed the antidepressant Zoloft to pregnant women without revealing the risk of it potentially causing birth defects.

The FDA's complex 501(k) medical device approval process consists of three levels, known as classes, that categorize the risk posed by products before their approval.

Bayer continues to shell out settlement compensation to those affected by allegedly serious blood clotting complications suffered as a result of Yaz and Yasmine use.

The FDA has ordered GlaskoSmithKline to add the risk of potentially fatal heart arrhythmia to the warning label of chemotherapy side effect treatment drug Zofran.

A new study has once again shown rare atypical femoral fractures in women share a link with the osteoporosis drug Fosamax, a drug taken to improve bone density.

A new Canadian study of 115,000 patients treated with the diabetes drug confirmed Actos can double the risk of bladder cancer.

Nearly 1,500 women have signed an online petition meant to help create awareness for the serious health problems associated with the intrauterine device Mirena.